Background A number of studies have shown poorer survival among cancer patients with
comorbidity. Several mechanisms may underlie this finding. In this review we summarize the …

Non-small-cell lung cancer (NSCLC) is a very common disease in the elderly population
and its incidence in this particular population is expected to increase further, because of the …

Background: As the population of the United States ages, there will be increasing numbers
of lung cancer patients with comorbidities at diagnosis. Comorbid conditions are important …

Rationale: The level of adherence to lung cancer treatment guidelines in the United States is
unclear. In addition, it is unclear whether previously identified disparities by racial or ethnic …

Prevention and management of chronic lung diseases (asthma, lung cancer, etc.) are of
great importance. While tests are available for reliable diagnosis, accurate identification of …

Background Many patients with advanced non-small-cell lung cancer (NSCLC) receive only
active supportive care because of poor performance status or presence of several …

Non-small cell lung cancer (NSCLC) represents the most common and fatal type of primary
lung malignancies. NSCLC is often diagnosed at later stages and requires systemic …

OBJECTIVES To compare the prognostic performance between different comorbidity
assessments of survival in patients with operated lung cancer. METHODS A total of 4508 …

Abstract Aim The Surgical Task Force at SIOG (International Society of Geriatric Oncology)
designed this survey to explore the surgical oncologists' approach toward elderly cancer …

This study investigated the impact of comorbidity in 555 patients with chronic lymphocytic
leukemia enrolled in two trials of the German Chronic Lymphocytic Leukemia Study Group …